Identified Risk Factors for Duchenne Muscular Dystrophy
UT Southwestern's plans
Currently, UT Southwestern provides clinical care to more than 100,000 patients hospitalized in around 80 facilities throughout U.S territories. Overseeing more than 2.2 million patient visits per year and is strongly committed to scientific research that aids in the development of new clinical treatments against conditions such as Duchenne muscular dystrophy.